Search Results - HORANLLI, Endri

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non-Hodgkin Lymphoma

    Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non-Hodgkin Lymphoma by GERECITANO, John, PORTLOCK, Carol, LASONOS, Alexia, ZHIGANG ZHANG, QIANXING MO, HORANLLI, Endri, ROJAS, Celeste N, ZELENETZ, Andrew D, O'CONNOR, Owen A, HAMLIN, Paul, MOSKOWITZ, Craig H, NOY, Ariela, STRAUS, David, SCHULMAN, Philip, DUMITRESCU, Otilia, SARASOHN, Debra, PAPPANICHOLAOU, Jennifer

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Rituximab, Cyclophosphamide, Bortezomib and Prednisone (R-CBorP): Final Results of a Phase I Trial Evaluating Two Dosing Schedules and the Safety of Overlapping Pegfilgrastim in Patients with Relapsed/Refractory Indolent and Mantle Cell Lymphomas

    Rituximab, Cyclophosphamide, Bortezomib and Prednisone (R-CBorP): Final Results of a Phase I Trial Evaluating Two Dosing Schedules and the Safety of Overlapping Pegfilgrastim in Pa... by Gerecitano, John, Portlock, Carol S., Hamlin, Paul A., Moskowitz, Craig H, Noy, Ariela, Straus, David J., Schulman, Philip, Dumitrescu, Otilia, Sarasohn, Debra, Pappanicholaou, Jennifer, Iassonos, Alexia, Zhang, Zhigang, Horanlli, Endri, Rojas, Celeste N, Zelenetz, Andrew D., O'Connor, Owen A

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: